FDA Bars Ingredients From Ranbaxy Plant

The FDA took another action against Ranbaxy, prohibiting it from making or selling drug ingredients from its Toansa, India, plant for the U.S. market.



from WSJ.com: US Business http://ift.tt/M0EPvx

via IFTTT